Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease

YILMAZ, YUSUF; ULUKAYA, Engin; Gul, Ozen; Arabul, Mahmut; Gul, Cuma; ATUĞ, ÖZLEN; YILMAZTEPE ORAL, ARZU; Aker, Sibel; Dolar, Enver

doi:10.1016/j.clinbiochem.2009.02.003

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease

Atıf İçin Kopyala

YILMAZ Y., ULUKAYA E., Gul O. O., Arabul M., Gul C. B., ATUĞ Ö., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.42, sa.9, ss.802-807, 2009 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 42 Sayı: 9
Basım Tarihi: 2009
Doi Numarası: 10.1016/j.clinbiochem.2009.02.003
Dergi Adı: CLINICAL BIOCHEMISTRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.802-807
Anahtar Kelimeler: Fatty liver, Biological markers, Receptor for advanced glycation endproducts (RAGE), Enzyme-linked immunosorbent assay, END-PRODUCTS AGES, INSULIN-RESISTANCE, SERUM-LEVELS, RAGE, FORM, PATHOGENESIS, GALECTIN-3, PROTEIN
Marmara Üniversitesi Adresli: Evet

Özet

Objectives: Levels of soluble receptor for advanced glycation endproducts (sRAGE) have been linked to several components of the metabolic syndrome. We tested the hypothesis that plasma levels of sRAGE may be associated with non-alcoholic fatty liver disease.